Company profile
BioDot - Discrete Droplet Dispensing
BioDot is the market leader in automated, high-throughput ultra-low volume dispensing systems for the manufacturing of todays most advanced diagnostics.
Financial period: 1 Apr 2024 to 31 Mar 2025
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
Last confirmation statement made up date
Last accounts made up date
AA | Transaction MzQzNTI2MDM5OWFkaXF6a2N4
Published 11 Sep 2024 09:28
Company registered at Companies House
1 Sep 2018 to 31 May 2021
Point-Of-Care Testing (POCT) allows the rapid diagnosis of disease and delivers the test results whilst the patient is present. This is in contrast to centralised testing where a patient has a sample taken (e.g. blood) which is then sent to a laboratory for analysis. POCT is becoming increasingly used due to the benefits of delivering diagnostic results a...
1 Nov 2012 to 31 Oct 2015
The Project Aims To Design And Develop An Automated Integrated "Plug And Play" For Management And Full Analysis Of DBS Type Blood Samples For The Early Life Which Currently Does Not Exist. Emergency Analysis Will Also Be Possible. It Will Be Flexible, It Could Handle Multiple Sessions.
